David Alderman: ASH25 is Live
David Alderman, President and CEO at Molekule Consulting, shared on LinkedIn:
”Silence before the field ruptures again.
First thing you see walking into ASH25.
Black letters on white. Lobby reeks of fresh carpet glue.
Four days in Orlando will break frontline logic, erase durability curves, and force every franchise team to rewrite 2026–2030 tonight.
Hematology never sleeps in December.
Everyone else does.
If you’re here, you feel it in your chest already.
If you’re not, pay attention.
What leaves these halls this week will outlive the building.
We are already live in every lineage that pays the bills.
If today’s late-breakers just detonated your 2027 budget, find us before your competitor does.
ASH25 is live.”
All from ASH25 featured in Hemostasis Today.
-
Jun 25, 2026, 14:13Christelle Orlando: 3 open Co-Chair Positions within the ISTH SSC Subcommittee on PAT
-
Jun 25, 2026, 14:10Brian A Beh: The Ten Truths That Changed How I Understand Stroke Recovery
-
Jun 25, 2026, 14:05Ryan O’Keefe: Exploring Gaucher’s Disease
-
Jun 25, 2026, 14:01Tasbeeh Ahmed: Exploring Anticoagulation in Antiphospholipid Syndrome
-
Jun 25, 2026, 13:58Maha Othman: Guest Editing a Landmark STH Special Issue on the Role of Red Blood Cells in Hemostasis and Thrombosis
-
Jun 25, 2026, 13:45Judith Verlaan: Body Fat Distribution and Its Role in Coagulation and VTE Risk
-
Jun 25, 2026, 13:38Sonal Sonu: Kell VS Rh – Not All Blood Group Systems Affect Erythropoiesis the Same Way
-
Jun 25, 2026, 13:35Mariann Bautista: Simplifying Coagulation Quality Control
-
Jun 25, 2026, 13:31Stéphane Laurent: Key Highlights of ISBT 2026 for INLOG